Citations to this article

Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie, William Pao, Noriko Motoi, William L. Gerald, William D. Travis, William Bornmann, Darren Veach, Bayard Clarkson, Jacqueline F. Bromberg
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3846–3856 doi:10.1172/JCI31871

Total citations by year

Year: 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 5 18 23 24 31 15 1 117
Citation information

Citations to this article in year 2012 (18)

Title and authors Publication Year
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
HS Hsu, JH Lin, TW Hsu, K Su, CW Wang, KY Yang, SH Chiou, SC Hung
Lung Cancer 2012
Impact of Collection and Storage of Lung Tumor Tissue on Whole Genome Expression Profiling
MB Freidin, N Bhudia, E Lim, AG Nicholson, WO Cookson, MF Moffatt
Journal of Molecular Diagnostics 2012
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
X Gao, H Wang, JJ Yang, X Liu, ZR Liu
Molecular Cell 2012
The role of pseudokinases in cancer
H Zhang, A Photiou, G Arnhild, J Stebbing, G Giamas
Cellular Signalling 2012
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
ZC Ding, G Zhou
Clinical and Developmental Immunology 2012
Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment
HJ Hugo, S Lebret, E Tomaskovic-Crook, N Ahmed, T Blick, DF Newgreen, EW Thompson, ML Ackland
Cancer Microenvironment 2012
Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α
K Kanda, H Komekado, T Sawabu, S Ishizu, Y Nakanishi, M Nakatsuji, R Akitake-Kawano, M Ohno, Y Hiraoka, M Kawada, K Kawada, Y Sakai, K Matsumoto, M Kunichika, T Kimura, H Seno, E Nishi, T Chiba
EMBO Molecular Medicine 2012
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
H Yi, HJ Cho, SM Cho, K Jo, JA Park, SH Lee, BJ Chang, JS Kim, HC Shin
Korean Journal of Physiology and Pharmacology 2012
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
X Jin, SH Kim, HM Jeon, S Beck, YW Sohn, J Yin, JK Kim, YC Lim, JH Lee, SH Kim, SH Kang, X Pian, MS Song, JB Park, YS Chae, YG Chung, SH Lee, YJ Choi, DH Nam, YK Choi, H Kim
Brain 2012
p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway
P Ozenne, D Dayde, E Brambilla, B Eymin, S Gazzeri
Oncogene 2012
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation
D Harada, N Takigawa, N Ochi, T Ninomiya, M Yasugi, T Kubo, H Takeda, E Ichihara, K Ohashi, S Takata, M Tanimoto, K Kiura
Cancer Science 2012
Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway
CL Yang, YY Liu, YG Ma, YX Xue, DG Liu, Y Ren, XB Liu, Y Li, Z Li
PloS one 2012
Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology1
ME Loveless, D Lawson, M Collins, MV Nadella, C Reimer, D Huszar, J Halliday, JC Waterton, JC Gore, TE Yankeelov
Neoplasia (New York, N.Y.) 2012
STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
BD Looyenga, D Hutchings, I Cherni, C Kingsley, GJ Weiss, JP Mackeigan
PloS one 2012
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
H Yi, HJ Cho, SM Cho, K Jo, JA Park, SH Lee, BJ Chang, JS Kim, HC Shin
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2012
Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
T Plönes, A Krohn, M Burger, H Veelken, B Passlick, J Müller-Quernheim, G Zissel
PloS one 2012
Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
N Singh, S Hussain, M Bharadwaj, N Kakkar, SK Singh, RC Sobti
Journal of Receptors and Signal Transduction 2012
STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma
Y Ho, SW Tsao, M Zeng, VW Lui
Cancer Letters 2012

Advertisement